← ANAPTYSBIO, INC ANAB
Market Price
$58.44
Market Cap
$1.63B
P/E Ratio
N/A
Revenue (FY 2025)
↑157.0% YoY
$234.60M
3-Yr CAGR: 183.6%
Net Income
↑90.9% YoY
-$13.23M
Net Margin: -5.6%
Free Cash Flow
↑114.5% YoY
$19.61M
FCF Yield: 1.20%
EPS (Diluted)
↑91.0% YoY
$-0.46
Basic: $-0.46
Return on Equity
Efficiency
-35.6%
ROA: -277.9%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (ANAB)
All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
- FY 2021: Revenue YoY (-15.8%) is identical to Gross Profit YoY (-15.8%). Verify the underlying Revenue and Gross Profit values for FY 2021 and FY 2020.
- FY 2022: Revenue YoY (-83.7%) is identical to Gross Profit YoY (-83.7%). Verify the underlying Revenue and Gross Profit values for FY 2022 and FY 2021.
- FY 2023: Revenue YoY (+66.8%) is identical to Gross Profit YoY (+66.8%). Verify the underlying Revenue and Gross Profit values for FY 2023 and FY 2022.
- FY 2024: Revenue YoY (+432.0%) is identical to Gross Profit YoY (+432.0%). Verify the underlying Revenue and Gross Profit values for FY 2024 and FY 2023.
| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $16.7M | — | $16.2M | $-4.3M | — | $-1.62 | — | $-9.0M | $-9.1M | — |
| FY 2017 | $10.0M | -40.1% | $8.2M | $-30.1M | -606.0% | $-1.52 | +6.2% | $-19.4M | $-19.7M | -117.3% |
| FY 2018 | $5.0M | -50.0% | $3.3M | $-61.7M | -105.0% | $-2.50 | -64.5% | $-48.5M | $-49.6M | -151.3% |
| FY 2019 | $8.0M | +60.0% | $7.0M | $-97.3M | -57.9% | $-3.60 | -44.0% | $-69.5M | $-70.3M | -41.9% |
| FY 2020 | $75.0M | +837.5% | $75.0M | $-19.9M | +79.5% | $-0.73 | +79.7% | $-14.2M | $-14.7M | +79.1% |
| FY 2021 | $63.2M | -15.8% | $63.2M | $-57.8M | -190.0% | $-2.11 | -189.0% | $-45.9M | $-47.3M | -221.1% |
| FY 2022 | $10.3M | -83.7% | $10.3M | $-128.7M | -122.7% | $-4.57 | -116.6% | $-73.6M | $-74.0M | -56.4% |
| FY 2023 | $17.2M | +66.8% | $17.2M | $-163.6M | -27.1% | $-6.08 | -33.0% | $-120.8M | $-121.6M | -64.4% |
| FY 2024 | $91.3M | +432.0% | $91.3M | $-145.2M | +11.2% | $-5.12 | +15.8% | $-135.3M | $-135.7M | -11.6% |
| FY 2025 | $234.6M | +157.0% | $98.6M | $-13.2M | +90.9% | $-0.46 | +91.0% | $19.7M | $19.6M | +114.5% |
Valuation
Market Price
$58.44
Market Cap
$1.63B
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
45.70
FCF Yield
1.20%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
42.04%
Operating Margin
20.42%
Net Margin
-5.64%
Return on Equity (ROE)
-35.56%
Return on Assets (ROA)
-277.87%
Asset Turnover
49.27x
Revenue 3-Yr CAGR
183.58%
Financial Health & Liquidity
Current Ratio
0.15
Cash Ratio
7.29
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$238.20M
Total Debt
N/A
Book Value / Share
$1.28
Cash Flow Efficiency
Operating Cash Flow
$19.70M
Capital Expenditures (CapEx)
$87.00K
Free Cash Flow
$19.61M
OCF / Revenue
8.40%
FCF / Revenue
8.36%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-0.46
EPS (Basic)
$-0.46
Dividends / Share
N/A
Book Value / Share
$1.28
EPS YoY Growth
91.02%
Balance Sheet (FY 2025)
Total Assets
$4.76M
Total Liabilities
$32.67M
Stockholders' Equity
$37.21M
Current Assets
$4.76M
Current Liabilities
$32.67M